BioSyent Inc.
RX.V
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 5.92M | 5.62M | 5.31M | 5.23M | 5.29M |
| Total Depreciation and Amortization | 670.80K | 650.60K | 592.00K | 223.00K | 232.10K |
| Total Amortization of Deferred Charges | 53.30K | 8.80K | 5.60K | 126.10K | 114.90K |
| Total Other Non-Cash Items | 150.20K | 109.70K | -69.70K | -564.80K | -538.30K |
| Change in Net Operating Assets | 2.09M | -1.11M | 644.00K | -69.00K | -3.20M |
| Cash from Operations | 8.72M | 5.11M | 6.31M | 4.94M | 1.90M |
| Capital Expenditure | -57.90K | -50.40K | -38.80K | -46.60K | -49.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.50M | 3.60M | 3.05M | 1.12M | 4.09M |
| Cash from Investing | -2.19M | 2.92M | 2.38M | 1.08M | 4.04M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -188.10K | -185.70K | -183.20K | -180.80K | -178.40K |
| Issuance of Common Stock | 277.20K | 308.90K | 250.40K | 155.10K | 104.90K |
| Repurchase of Common Stock | -4.79M | -5.14M | -5.76M | -2.79M | -3.37M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.55M | -1.52M | -1.52M | -1.50M | -1.47M |
| Other Financing Activities | -54.30K | -56.70K | -59.20K | -61.60K | -64.00K |
| Cash from Financing | -4.93M | -5.13M | -5.68M | -3.62M | -4.06M |
| Foreign Exchange rate Adjustments | -2.10K | 3.10K | 3.70K | -130.40K | -57.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.60M | 2.90M | 3.02M | 2.26M | 1.82M |